Vitrolife AB (publ) (VTRLY)

Market Cap	2.20B
Revenue (ttm)	359.64M
Net Income (ttm)	49.61M
Shares Out	n/a
EPS (ttm)	0.37
PE Ratio	44.26
Forward PE	35.41
Dividend	0.07 (0.42%)
Ex-Dividend Date	May 2, 2025

Volume	100
Average Volume	29
Open	16.39
Previous Close	16.39
Day's Range	16.39 - 16.39
52-Week Range	13.21 - 25.00
Beta	1.83
RSI	0.08
Earnings Date	Jul 17, 2025

About Vitrolife AB

Vitrolife AB (publ) provides assisted reproduction products in Europe, the Middle East, Africa, Asia-Pacific, and the Americas. It offers sperm processing, oocyte retrieval needles, micromanipulation pipettes, time-lapse systems, and evaluation tools, laser and imaging systems, IVF media and oil, embryo transfer, cryopreservation, and genomics kits. The company also provides eWitness and Labware products, such as dishes, pipettes, tubes, and VitroTemp. Vitrolife AB (publ) was incorporated in 1989 and is based in Gothenburg, Sweden.

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1989
• Employees: 1,169
• Stock Exchange: OTCMKTS
• Ticker Symbol: VTRLY

Financial Performance

Financial numbers in SEK